Conference Correspondent

A nurse-led initiative to discharge patients before noon has paid off at the Mount Sinai Hospital, NY, according to Kathleen Edmondson-Martin, MA, RN, OCN, Clinical Nurse Manager in the hospital's bone marrow transplant unit. Read More ›

Response is a poor outcome measure of immunotherapy, according to Tanguy Seiwert, MD, who addressed this and other concerning issues in immunotherapy at the 2016 Multidisciplinary Head and Neck Cancer Symposium. Read More ›

Women being treated for cancer appear to benefit from a psychological intervention aimed at counseling them on fertility preservation, according to a study reported by the National Comprehensive Cancer Network. Read More ›

Preliminary results from a prospective study suggest that assessing psychological factors in cancer patients prior to initiating therapy can identify patients most at risk for emotional distress who might need psychosocial support. Read More ›

Bone mineral density testing is underutilized in women with BRCA mutations who undergo risk-reducing salpingo-oophorectomy (RRSO). In a review of health surveillance data from a single institution, only about half of these women were screened for osteoporosis using dual-energy x-ray absorptiometry (DEXA) scan, despite being at significantly increased risk for the disease. Read More ›

Researchers reported results of a real-world prospective study that evaluated different geriatric assessment tools and comorbidity indices as well as standard disease-related prognostic factors in consecutive unselected patients aged >65 years with symptomatic multiple myeloma (MM). Read More ›

Researchers reported results of a population-based study examined sex, race, and age-stratified differences in incidence, mortality, and survival from 1973 to 2012 for 89,867 myeloma patients by using national epidemiologic data. Read More ›

Researchers presented results of patient-reported assessments of general health status as well as pain severity and interference using pooled data from 3 denosumab registrational trials that had enrolled patients with advanced cancers including multiple myeloma (MM). Read More ›